Karen Howland

<i>In Vitro</i> and <i>In Vivo</i> Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile

Carmela Mascio, Lawrence I. Mortin, Karen Howland et al. · Antimicrobial Agents and Chemotherapy · 2012 · 78 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Structure–Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of <i>Clostridium difficile</i>-Associated Diarrhea

Ning Yin, Jing Li, Yong He et al. · Journal of Medicinal Chemistry · 2015 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Reduced pulmonary surfactant interaction of daptomycin analogs via tryptophan replacement with alternative amino acids

Yong He, Jing Li, Nin Yin et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 22 citations

Pharmacy, Biochemistry, Pharmacology +13

In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents

Cédric Jacqueline, Karen Howland, Laurent Chesnel · Journal of Global Antimicrobial Resistance · 2017 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +8